Year archive

Aspira Pathlab & Diagnostics Limited — 2026 filings

All 9 regulatory filings released by Aspira Pathlab & Diagnostics Limited (540788) in 2026, sourced directly from the official regulator.

9 Filings

2026 Period

2026 filings (9)

Filing	Released	Lang
The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years Board/Management Information	2026-05-23	English
The disclosure regarding of Mrs. Neetu Maurya as a Company Secretary of the company with effect from 24.05.2026 was inadvertently filed under change in Control Board/Management Information	2026-05-23	English
Appointment of Mrs. Neetu Maurya as Company Secretary of the Company With Effect From 24.05.2026 Board/Management Information	2026-05-23	English
Appointment of M/s. Vishal J Bhanushali & Associates, as an Internal Auditor for F.Y. 2026-27 of the Company Board/Management Information	2026-05-23	English
Integrated Financial Results as on March 31, 2026 Regulatory Filings	2026-05-23	English
Board Meeting outcome for Dated May 23, 2026 Regulatory Filings	2026-05-23	English
Outcome of the Board Meeting dated May 23, 2026 Interim / Quarterly Report FY 2026	2026-05-23	English
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve Audited Standalone .... Regulatory Filings	2026-05-18	English
Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement for the attention of the Equity Shareholders of the Aspira Pathlab & Diagnostics .... M&A Activity	2026-05-18	English